FDA finds no cancer link with blood pressure pills

Jun 02, 2011

(AP) -- The Food and Drug Administration says there is no link between a popular group of blood pressure medications and cancer, despite a recent paper suggesting a slightly higher risk in patients taking the drugs.

In an analysis of 60,000 patients published last summer, experts found a link between people taking medicines known as angiotensin-receptor blockers and cancer. The drugs are taken by millions of people worldwide for conditions like , heart problems and .

But the FDA says its own review of 31 studies involving 155,000 patients did not show any relationship between the drugs and cancer. The review is the largest of its kind, according to the FDA

The drugs are sold under brand names including Diovan, Micardis and Avapro.

Explore further: Flu vaccine may hold key to preventing heart disease

not rated yet
add to favorites email to friend print save as pdf

Related Stories

FDA panel backs anemia drugs for kidney disease

Oct 18, 2010

(AP) -- Federal health advisers say patients with failing kidneys should continue taking a group of widely used anemia drugs, despite a recent study showing they can increase the risk of stroke.

FDA: Arthritis drugs pose cancer risk to children

Aug 04, 2009

(AP) -- Federal regulators on Tuesday added stronger warnings to a group of best-selling drugs used to treat arthritis and other inflammatory diseases, saying they can increase the risk of cancer in children and adolescents.

FDA questions safety of Glaxo kidney cancer drug

Oct 01, 2009

(AP) -- Federal regulators said Thursday an experimental kidney cancer drug from GlaxoSmithKline may cause liver problems, potentially outweighing its ability to slow the disease.

High blood pressure pill cuts risk of Parkinson's disease

Feb 06, 2008

People taking a widely used group of drugs known as calcium channel blockers to treat high blood pressure also appear to be cutting their risk of Parkinson’s disease, according to a study published in the February 6, 2008, ...

Recommended for you

Supercomputers link proteins to drug side effects

Oct 20, 2014

New medications created by pharmaceutical companies have helped millions of Americans alleviate pain and suffering from their medical conditions. However, the drug creation process often misses many side ...

No added benefit proven for umeclidinium/vilanterol in COPD

Oct 20, 2014

The drug combination umeclidinium/vilanterol (trade name Anoro) has been approved since May 2014 for adults with chronic obstructive pulmonary disease (COPD). In an early benefit assessment pursuant to the Act on the Reform ...

User comments : 0